Ginkgo Bioworks Holdings Inc vs Eni SpA — how do they compare? Ginkgo Bioworks Holdings Inc trades at $9.06 (market cap $591.19M), while Eni SpA trades at $49.51 (market cap $71.48B). The key difference: Eni SpA is far larger — about 120.9× Ginkgo Bioworks Holdings Inc's market cap, and Eni SpA pays a 4.94% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| DNA | E | |
|---|---|---|
Market Cap | $591.19M | $71.48B |
Sector | Health | Energy |
52-Week High | $16.14 | $57.61 |
52-Week Low | $5.48 | $32.93 |
Enterprise Value | $628.43M | $90.39B |
Dividend Yield | — | 4.94% |
Trailing returns across standard periods
Latest headlines on both assets
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →Eni is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, the company produced 0.8 million barrels of liquids and 4.6 billion cubic feet of natural gas per day. At end-2021, Eni held reserves of 6.6 billion barrels of oil equivalent, 49% of which are liquids. The Italian government owns a 30.1% stake in the company. Eni is placing its renewable and low-carbon business in a separate entity, Plentitude
Read more on E →